Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

JOSAMYCIN FOR PEAK IDENTIFICATION CRS (25 MG)

JOSAMYCIN FOR PEAK IDENTIFICATION CRS (25 MG)

16846-24-5

DISCOVER
TROPICAMIDE FOR PEAK IDENTIFICATION CRS (10 MG)

TROPICAMIDE FOR PEAK IDENTIFICATION CRS (10 MG)

1508-75-4

DISCOVER
TESTOSTERONE ENANTATE FOR SYSTEM SUITABILITY CRS (2 MG)

TESTOSTERONE ENANTATE FOR SYSTEM SUITABILITY CRS (2 MG)

315-37-7

DISCOVER
CEFPODOXIME PROXETIL FOR IMPURITY H IDENTIFICATION CRS (10 M

CEFPODOXIME PROXETIL FOR IMPURITY H IDENTIFICATION CRS (10 M

87239-81-4

DISCOVER
TRIMEBUTINE MALEATE CRS (10 MG)

TRIMEBUTINE MALEATE CRS (10 MG)

34140-59-5

DISCOVER
ONDANSETRON  IMPURITY F CRS (10 MG)

ONDANSETRON IMPURITY F CRS (10 MG)

693-98-1

DISCOVER
DERMATAN SULFATE AND OVER- SULFATED CHONDROITIN SULFATE CRS

DERMATAN SULFATE AND OVER- SULFATED CHONDROITIN SULFATE CRS

NA

DISCOVER
HYDROXYETHYL STARCH (HIGH MW)CRS (800 MG)

HYDROXYETHYL STARCH (HIGH MW)CRS (800 MG)

9005-27-0

DISCOVER
ARISTOLOCHIA HRS (140 MG)

ARISTOLOCHIA HRS (140 MG)

NA

DISCOVER
SUCRALFATE CRS (20 MG)

SUCRALFATE CRS (20 MG)

54182-58-0

DISCOVER
EQUISETUM PALUSTRE HRS (200 MG)

EQUISETUM PALUSTRE HRS (200 MG)

NA

DISCOVER
ONDANSETRON  IMPURITY E CRS (15 MG)

ONDANSETRON IMPURITY E CRS (15 MG)

288-32-4

DISCOVER